| [1] |
张明悦, 侯 艳. 脂联素在特发性肺纤维化中的作用机制及应用研究进展[J/OL]. 解放军医学杂志, 1-12[2025-11-1]. .
|
| [2] |
MARTINEZ F J, COLLARD H R, PARDO A, et al. Idiopathic pulmonary fibrosis[J]. Nat Rev Dis Primers, 2017, 3: 17074.
|
| [3] |
LI X H, WANG Y H, LIANG J J, et al. Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway[J]. Phytother Res, 2021, 35(10): 5808-5822.
|
| [4] |
BERHAN A, HARRIS T, JAFFAR J, et al. Cellular microenvironment stiffness regulates eicosanoid production and signaling pathways[J]. Am J Respir Cell Mol Biol, 2020, 63(6): 819-830.
|
| [5] |
JUNG M Y, KANG J H, HERNANDEZ D M, et al. Fatty acid synthase is required for profibrotic TGF-β signaling[J]. FASEB J, 2018, 32(7): 3803-3815.
|
| [6] |
KREUTER M, BONELLA F, MAHER T M, et al. Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis[J]. Thorax, 2017, 72(2): 148-153.
|
| [7] |
XU M M, ZHOU H, HU P, et al. Identification and validation of immune and oxidative stress-related diagnostic markers for diabetic nephropathy by WGCNA and machine learning[J]. Front Immunol, 2023, 14: 1084531.
|
| [8] |
XU S, LI X Z, ZHANG S H, et al. Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study[J]. BMC Med, 2023, 21(1): 179.
|
| [9] |
SINHA R A, SINGH B K, YEN P M. Direct effects of thyroid hormones on hepatic lipid metabolism[J]. Nat Rev Endocrinol, 2018, 14(5): 259-269.
|
| [10] |
WANG L, LI Z Z, WAN R Y, et al. Single-cell RNA sequencing provides new insights into therapeutic roles of thyroid hormone in idiopathic pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2023, 69(4): 456-469.
|
| [11] |
ENOMOTO N, OYAMA Y, YASUI H, et al. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis[J]. Sci Rep, 2019, 9(1): 10484.
|
| [12] |
WANG X, YANG J, WU L Q, et al. Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway[J]. Bioengineered, 2022, 13(4): 10098-10110.
|
| [13] |
SHI W D, ZHU Q, GU J, et al. Anti-IL-17 antibody improves hepatic steatosis by suppressing interleukin-17-related fatty acid synthesis and metabolism[J]. Clin Dev Immunol, 2013, 2013: 253046.
|
| [14] |
SENOO S, HIGO H, TANIGUCHI A, et al. Pulmonary fibrosis and type-17 immunity[J]. Respir Investig, 2023, 61(5): 553-562.
|
| [15] |
YAMAGUCHI K, IWAMOTO H, MAZUR W, et al. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis[J]. Respir Res, 2020, 21(1):145.
|
| [16] |
DENG C H, PRESLE N, PIZARD A, et al. Beneficial impact of eicosapentaenoic acid on the adverse effects induced by palmitate and hyperglycemia on healthy rat chondrocyte[J]. Int J Mol Sci, 2024, 25(3):1810.
|
| [17] |
CRAIG V J, ZHANG L, HAGOOD J S, et al. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2015, 53(5): 585-600.
|
| [18] |
DAS S, SUBRAMANIYAM N, ALÉN R, et al. Ablation of secreted phosphoprotein-1 in hepatocytes increases fatty acid oxidation and ameliorates alcohol-associated liver disease[J]. Alcohol Clin Exp Res (Hoboken), 2024, 48(5): 781-794.
|
| [19] |
MORSE C, TABIB T, SEMBRAT J, et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis[J]. Eur Respir J, 2019, 54(2): 1802441.
|
| [20] |
YUE B Q, XIONG D, CHEN J, et al. SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K/Akt/mTOR pathway[J]. Respir Res, 2024, 25(1): 362.
|
| [21] |
NAZLI S A, LOESER R F, CHUBINSKAYA S, et al. High fat-diet and saturated fatty acid palmitate inhibits IGF-1 function in chondrocytes[J]. Osteoarthritis Cartilage, 2017, 25(9): 1516-1521.
|
| [22] |
ZHANG Y C, LIANG J J, CAO N D, et al. Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-κB/NLRP3 pathway driven by IGF1/ROS-mediated AKT/GSK3β signals[J]. Cell Death Discov, 2022, 8(1): 500.
|
| [23] |
DING C C, GUO Z Z, LIAO Q, et al. Network pharmacology and machine learning reveal salidroside’s mechanisms in idiopathic pulmonary fibrosis treatment[J]. J Inflamm Res, 2024, 17: 9453-9467.
|
| [24] |
WU Z N, CHEN H, KE S W, et al. Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis[J]. Sci Rep, 2023, 13(1): 16559.
|
| [25] |
PERROT C Y, KARAMPITSAKOS T, HERAZO-MAYA J D. Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis[J]. Am J Physiol Cell Physiol, 2023, 325(4): C1046-C1057.
|
| [26] |
YANG X L, LIU Z Q, ZHOU J W, et al. SPP1 promotes the polarization of M2 macrophages through the Jak2/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis[J]. Int J Mol Med, 2024, 54(4): 89.
|